Authors:
Renyi, L
Evenden, JL
Fowler, CJ
Jerning, E
Kelder, D
Lake-Bakaar, D
Larsson, LG
Mohell, N
Sallemark, M
Ross, SB
Citation: L. Renyi et al., The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist, J PHARM EXP, 299(3), 2001, pp. 883-893
Authors:
Granas, C
Nordquist, J
Mohell, N
Larhammar, D
Citation: C. Granas et al., Site-directed mutagenesis of the 5-HT1B receptor increases the affinity of5-HT for the agonist low-affinity conformation and reduces the intrinsic activity of 5-HT, EUR J PHARM, 421(2), 2001, pp. 69-76
Authors:
Hammarberg, E
Nordvall, G
Leideborg, R
Nylof, M
Hanson, S
Johansson, L
Thorberg, SO
Tolf, BR
Jerning, E
Svantesson, GT
Mohell, N
Ahlgren, C
Westlind-Danielsson, A
Csoregh, I
Johansson, R
Citation: E. Hammarberg et al., Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor, J MED CHEM, 43(15), 2000, pp. 2837-2850
Authors:
Homan, EJ
Kroodsma, E
Copinga, S
Unelius, L
Mohell, N
Wikstrom, HV
Grol, CJ
Citation: Ej. Homan et al., Structural analogues of 5-OMe-BPAT: Synthesis and interactions with dopamine D-2, D-3, and serotonin 5-HT1A receptors, BIO MED CH, 7(6), 1999, pp. 1111-1121
Authors:
Caldirola, P
Chowdhury, R
Unelius, L
Mohell, N
Hacksell, U
Johansson, AM
Citation: P. Caldirola et al., Novel derivatives of 3-(dipropylamino) chroman. Interactions with 5-HT1A and D-2A receptors., BIOORG MED, 9(11), 1999, pp. 1583-1586
Authors:
Homan, EJ
Copinga, S
Elfstrom, L
van der Veen, T
Hallema, JP
Mohell, N
Unelius, L
Johansson, R
Wikstrom, HV
Grol, CJ
Citation: Ej. Homan et al., 2-aminotetralin-derived substituted benzamides with mixed dopamine D-2, D-3, and serotonin 5-HT1A receptor binding properties: A novel class of potential atypical antipsychotic agents, BIO MED CH, 6(11), 1998, pp. 2111-2126